We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Puretech Health Plc | LSE:PRTC | London | Ordinary Share | GB00BY2Z0H74 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 0.71% | 214.00 | 213.00 | 214.50 | 225.00 | 211.00 | 219.00 | 536,441 | 15:40:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Home Health Care Services | 23.75M | -50.35M | -0.1839 | -11.66 | 587.44M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/9/2021 11:37 | Hopefully that’s a bit of a clue, would generate significant interest I expect. | lendmeafiver | |
30/9/2021 09:52 | I've already given up on the LSE to work out what positive phase2 results for LYT100 for long Covid should do for the share price......no I've full confidence that the Nasdaq will be the front runners there. | volvo | |
30/9/2021 07:34 | lmaf, yes Puretech have been banging the drum throughout September for LYT100, they must know early results look good re Long Covid. Directors buying too. Check out Puretech Twitter.....seems a lead into news PureTech @PureTechH · 21 September 2021 Progressive fibrosing interstitial lung diseases impact >850,000 people globally, yet currently available treatments don’t meet patients’ needs & ~75% of #IPF patients are not on treatment. This #PFMonth, we’re spotlighting our dedication to helping patients with IPF & #LongCovid Would be slightly red faced if LYT100 wasnt a success in Long Covid phase2 trials | volvo | |
29/9/2021 19:08 | Long Covid will interest the market. | lendmeafiver | |
29/9/2021 16:26 | Strong Akili news today. Markets sanguine atm. | volvo | |
28/9/2021 17:47 | Well i've topped up today sub 350p to double my current position. News on LYT100 in long covid due anytime, which will read v good, but imo phase 2 results for VE303 for Vedanta (41pc owned) will be game changer. Lets see what happens | volvo | |
28/9/2021 12:03 | Buy at 11am, sell at 4pm, rinse repeat. | lendmeafiver | |
28/9/2021 11:58 | Agree, someone was collecting stock at 372-377p this morning, great intraday trading stock | volvo | |
28/9/2021 11:53 | What’s the betting this finishes the day back at 368p? | lendmeafiver | |
27/9/2021 17:19 | Started good like news coming | volvo | |
27/9/2021 17:18 | ....we'll be millionaires | volvo | |
26/9/2021 18:19 | This week...... | volvo | |
23/9/2021 19:08 | 379p in US | volvo | |
23/9/2021 10:42 | It will get back into the £4s without news if the buying continues, particularly on the Nasdaq. | lendmeafiver | |
23/9/2021 08:46 | lmaf over 380p on first show. Really wants to motor on here, just needs some news. Maybe soon who knows | volvo | |
22/9/2021 19:40 | Yes it was an interesting update on Glyph Technology. Nasdaq volume continues to improve, next target on LSE 380, don’t think it will be long. | lendmeafiver | |
22/9/2021 15:26 | “What’s remarkable about this study is that the COX-2 inhibitor was able to meaningfully repattern the chaotic lymphatic structure in obese mice when it was delivered directly to the mesenteric lymphatics with our Glyph technology platform, and that repatterning was accompanied by a substantial decrease in both weight gain and insulin resistance,” said Joseph Bolen, Ph.D., Chief Scientific Officer at PureTech. “We are excited to continue to build off of this pioneering research to identify and advance new potential treatment applications of this platform.” | rambutan2 | |
22/9/2021 14:50 | Lots of buying again today. | lendmeafiver | |
22/9/2021 09:19 | Expecting Vedanta news re VE303 this month...... | volvo | |
21/9/2021 15:03 | as one of my largest holdings is novo nordisk this is bitter sweet! | edwardt | |
21/9/2021 06:40 | lmaf....yes 7.3pc up, 387p,in a awful market day, yesterdays news was obviously better received by people on the Nasdaq who can evaluate these things. Looks like we have a cure for obesity! | volvo | |
20/9/2021 21:34 | Looking good on the Nasdaq this evening. | lendmeafiver | |
20/9/2021 17:47 | Glyph technology.....4pm news....LSE so what | volvo | |
20/9/2021 09:40 | Very strong here today in weak markets, following threw on last weeks rise and strong volume, lets see what the US wakes up like, but my thoughts are the new investor is stateside. | volvo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions